SGHT
Medical Devices · Healthcare
COO
2025-11-05–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Sight Sciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get SGHT alertsAlison Bauerlein is recorded as COO at Sight Sciences, Inc. (SGHT). The newest filing on record that lists Alison Bauerlein as COO at Sight Sciences, Inc. (SGHT) is dated April 22, 2026. Earlier roles on record: CFO at Inogen Inc (INGN) until December 13, 2021. Sight Sciences, Inc. reported in an 8-K filed November 6, 2025 that Alison Bauerlein was appointed Chief Operating Officer, effective November 5, 2025. Sight Sciences, Inc. reported in an 8-K filed April 3, 2023 that Alison Bauerlein was appointed Chief Financial Officer and Treasurer, effective April 3, 2023. The proxy statement of Sight Sciences, Inc. reports total compensation of $1,626,754 for Alison Bauerlein in fiscal 2025, including a base salary of $474,900. Disclosed compensation is on record for 8 fiscal years. Alison Bauerlein has spoken on 1 earnings call across 1 company, most recently for Sight Sciences, Inc. on March 4, 2026. Sight Sciences, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Sight Sciences, Inc. includes Paul Badawi (CEO and Board Member), James Rodberg (CFO), Jim Rodberg (CFO) and 7 others.
“Effective as of November 5, 2025, the board of directors of the Company (the "Board") promoted Alison Bauerlein to the position of Chief Operating Officer of the Company.”
“Effective April 3, 2023, Alison Bauerlein was appointed by the Board of Directors (the "Board") of Sight Sciences, Inc. (the "Company") to serve as the Company's Chief Financial Officer and Treasurer.”
“So remember, when you look at the IDE revenue, that includes a mix of smart lids sold as well as smart hubs sold. So, the ASP would be reflective of that mix within those segments.”
SEC 8-K
2025-11-05–present
Start not stated–present
Last confirmed April 22, 2026
Proxy statement
Start not stated–2021-03-23
Last confirmed by a filing; no departure on record
Start not stated–2025-04-23
Last confirmed by a filing; no departure on record
Start not stated–2021-12-13
SGHT
Medical Devices · Healthcare
COO
2025-11-05–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Sight Sciences, Inc. (SGHT) | Chief Operating Officer | $474,900 | $1,626,754 |
| 2024 | Sight Sciences, Inc. (SGHT) | Chief Operating Officer | $450,000 | $2,238,543 |
| 2023 | Sight Sciences, Inc. (SGHT) | Chief Financial Officer | $306,185 | $1,848,183 |
| 2021 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $368,412 | $1,920,973 |
| 2020 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $369,823 | $1,173,453 |
| 2019 | Inogen Inc (INGN) | Former Executive Vice President, Finance and Chief Financial Officer | $365,458 | $1,170,980 |
| 2018 | Inogen Inc (INGN) | Executive Vice President, Finance and Chief Financial Officer | $355,212 | $1,242,433 |
| 2017 | Inogen Inc (INGN) | Executive Vice President, Finance and Chief Financial Officer | $336,251 | $1,157,235 |